Table on assessment times for Concerned Member State cases
Updated 18 March 2025
Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within 30 days | Share of cases within 30 days in per cent | |
Concerned Member State cases | ||||||
1st quarter 2023 | 112 | 30 | 82 | 75 | 31 | 41 |
2nd quarter 2023 | 89 | 30 | 59 | 80 | 23 | 29 |
3rd quarter 2023 | 57 | 30 | 27 | 116 | 55 | 47 |
4th quarter 2023 | 123 | 30 | 93 | 66 | 23 | 35 |
1st quarter 2024 | 69 | 30 | 39 | 84 | 36 | 43 |
2nd quarter 2024 | 87 | 30 | 57 | 112 | 55 | 49 |
3rd quarter 2024 | 116 | 30 | 86 | 150 | 59 | 39 |
4th quarter 2024 | 91 | 30 | 61 | 161 | 72 | 45 |
Table 2. Concerned member state cases – Human medicines | ||||||
Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within 30 days | Share of cases within 30 days in per cent | |
Concerned Member State cases - HUM | ||||||
1st quarter 2023 | 117 | 30 | 87 | 70 | 28 | 40 |
2nd quarter 2023 | 90 | 30 | 60 | 70 | 21 | 30 |
3rd quarter 2023 | 61 | 30 | 31 | 91 | 42 | 46 |
4th quarter 2023 | 135 | 30 | 105 | 59 | 18 | 31 |
1st quarter 2024 | 76 | 30 | 46 | 76 | 28 | 37 |
2nd quarter 2024 | 95 | 30 | 65 | 95 | 44 | 46 |
3rd quarter 2024 | 128 | 30 | 98 | 126 | 39 | 31 |
4th quarter 2024 | 95 | 30 | 65 | 152 | 66 | 43 |
Table 3. Concerned member state cases – Veterinary medicines | ||||||
Average assessment time | Target days | Difference between assessment time and target days | No. of cases measured No. of Drug IDs | No. of cases within 30 days | Share of cases within 30 days in per cent | |
Concerned Member State cases - VET | ||||||
1st quarter 2023 | 35 | 30 | 5 | 5 | 3 | 60 |
2nd quarter 2023 | 80 | 30 | 50 | 10 | 2 | 20 |
3rd quarter 2023 | 42 | 30 | 12 | 25 | 13 | 52 |
4th quarter 2023 | 16 | 30 | -14 | 7 | 5 | 71 |
1st quarter 2024 | 7 | 30 | -23 | 8 | 8 | 100 |
2nd quarter 2024 | 44 | 30 | 14 | 17 | 11 | 65 |
3rd quarter 2024 | 57 | 30 | 27 | 24 | 20 | 83 |
4th quarter 2024 | 19 | 30 | -11 | 9 | 6 | 67 |